How pancreatic alpha cells respond in insulin resistance and type 2 diabetes

Pancreatic islet alpha cell response to insulin resistance and type 2 diabetes

NIH-funded research Veterans Health Administration · NIH-11212796

This project looks at why pancreatic alpha cells release too much glucagon in adults with insulin resistance or type 2 diabetes.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionVeterans Health Administration NIH-funded
Lab location1 site (Nashville, United States)
Project IDNIH-11212796 on NIH RePORTER

What this research studies

Researchers will study human pancreatic islet alpha and beta cells to see how key gene regulators, like the transcription factor MAFB, change under diabetes-related stress such as high fat, oxidative stress, or insulin resistance. They will examine human islet tissue and laboratory models to measure hormone secretion (glucagon and insulin) and patterns of gene activity. The team will compare samples from people with and without type 2 diabetes to identify molecular changes that may drive excess glucagon. Results will be used to identify potential targets for therapies that restore normal hormone balance.

Who could benefit from this research

Good fit: Adults with insulin resistance or type 2 diabetes, particularly veterans receiving care through the VA who are willing to provide clinical data or tissue samples, would be the most relevant participants.

Not a fit: People without insulin resistance or those with unrelated conditions (for example some non–type 2 forms of diabetes or other metabolic disorders) are unlikely to receive direct benefit from this project.

Why it matters

Potential benefit: If successful, this work could point to new treatments that reduce excess glucagon and improve blood sugar control in people with type 2 diabetes.

How similar studies have performed: Previous laboratory studies have shown MAFB changes in stressed human islets, but translating these findings into patient treatments is still a new and emerging approach.

Where this research is happening

Nashville, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Adult-Onset Diabetes Mellitus
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.